Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07642908

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

Sponsor: University of Michigan

View on ClinicalTrials.gov

Summary

This study explores how a specific genetic mutation of leucine-rich repeat kinase 2 (LRRK2) affects individuals with Parkinson's disease (PD), comparing those with the mutation to others with Parkinson's disease and without the mutation (iPD). Participants will complete positron emission tomography (PET) and magnetic resonance imaging (MRI) brain imaging, cognitive tests, motor tests, sensory tests, and questionnaires. The aims of this study are to compare brain chemicals in LRRK2 PD patients with iPD patients and to correlate brain chemicals with motor and cognitive tests in LRRK2 PD and iPD patients.

Key Details

Gender

All

Age Range

45 Years - Any

Study Type

OBSERVATIONAL

Enrollment

15

Start Date

2025-09-18

Completion Date

2026-09-17

Last Updated

2026-06-11

Healthy Volunteers

No

Locations (1)

University of Michigan

Ann Arbor, Michigan, United States